Anti-Human CCR4 Therapeutic Antibody (208)

This single chain antibody fragment which binds to an epitope in the extracellular domain of human CC chemokine receptor 4 (CCR4) and is capable of inhibiting the binding of macrophage-derived chemokine (MDC) and/or thymus and activation regulated chemokine (TARC) to CCR4. It is also effective in the treatment of tumors, viral infections and other diseases and conditions in which CCR4+ cells are involved such as inflammatory or immune disorders.
Supplier Creative Biolabs
Product # TAB-1521CL
Pricing Inquiry
Type Human antibody
Applications FC, Inhib
Host Human
Target CC chemokine receptor 4 (CCR4)
Feedback